首页 > 最新文献

Journal of Research in Pharmacy Practice最新文献

英文 中文
Influence of Cigarette Smoking Habit on Clozapine-to-Norclozapine Ratio in Male Patients. 吸烟习惯对男性患者氯氮平与诺氯氮平比例的影响
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_37_23
Roberto Lozano, Carina Bona

Objective: This study aimed to evaluate the influence of cigarette smoking habit on the clozapine (CLZ)-to-norclozapine (norCLZ) ratio in male patients.

Methods: The sample consisted of plasma concentration of CLZ and norCLZ data set. The mean values of CLZ, norCLZ, and CLZ-to-norCLZ, between male patients who smoke versus nonsmokers were compared.

Findings: CLZ mean plasma level of 142 ± 80 ng/ml and 305 ± 159 ng/ml, norCLZ mean plasma level of 93 ± 72 ng/ml and 234 ± 62 ng/ml, and mean CLZ-to-norCLZ plasma level ratio of 2.1 ± 1.1 and 1.5 ± 0.5, were obtained respectively for male patients who smoke and nonsmokers.

Conclusion: This study has shown a significant decrease in CLZ and norCLZ plasma levels, and an increase in the CLZ-to-norCLZ ratio, in smokers as compared to nonsmokers, due to an increase in the clearance of CLZ and norCLZ by smoking induction of CYP 1A2 and glucuronidation by uridyl glucuronyl transferase enzymes (UGT), mainly UGT 1A4, respectively, as the most probable cause.

研究目的本研究旨在评估吸烟习惯对男性患者氯氮平(CLZ)-去氯氮平(norCLZ)比值的影响:样本包括CLZ和norCLZ的血浆浓度数据集。比较了吸烟与不吸烟男性患者的 CLZ、norCLZ 和 CLZ 与 norCLZ 的平均值:结果:吸烟和不吸烟男性患者的 CLZ 平均血浆水平分别为 142 ± 80 ng/ml 和 305 ± 159 ng/ml,norCLZ 平均血浆水平分别为 93 ± 72 ng/ml 和 234 ± 62 ng/ml,CLZ 与 norCLZ 平均血浆水平比分别为 2.1 ± 1.1 和 1.5 ± 0.5:本研究表明,与不吸烟者相比,吸烟者的CLZ和norCLZ血浆水平明显下降,CLZ与norCLZ的比值上升,这可能是由于吸烟分别诱导CYP 1A2和尿苷葡萄糖醛酸转移酶(UGT)(主要是UGT 1A4)的葡萄糖醛酸化作用,从而增加了CLZ和norCLZ的清除率。
{"title":"Influence of Cigarette Smoking Habit on Clozapine-to-Norclozapine Ratio in Male Patients.","authors":"Roberto Lozano, Carina Bona","doi":"10.4103/jrpp.jrpp_37_23","DOIUrl":"10.4103/jrpp.jrpp_37_23","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the influence of cigarette smoking habit on the clozapine (CLZ)-to-norclozapine (norCLZ) ratio in male patients.</p><p><strong>Methods: </strong>The sample consisted of plasma concentration of CLZ and norCLZ data set. The mean values of CLZ, norCLZ, and CLZ-to-norCLZ, between male patients who smoke versus nonsmokers were compared.</p><p><strong>Findings: </strong>CLZ mean plasma level of 142 ± 80 ng/ml and 305 ± 159 ng/ml, norCLZ mean plasma level of 93 ± 72 ng/ml and 234 ± 62 ng/ml, and mean CLZ-to-norCLZ plasma level ratio of 2.1 ± 1.1 and 1.5 ± 0.5, were obtained respectively for male patients who smoke and nonsmokers.</p><p><strong>Conclusion: </strong>This study has shown a significant decrease in CLZ and norCLZ plasma levels, and an increase in the CLZ-to-norCLZ ratio, in smokers as compared to nonsmokers, due to an increase in the clearance of CLZ and norCLZ by smoking induction of CYP 1A2 and glucuronidation by uridyl glucuronyl transferase enzymes (UGT), mainly UGT 1A4, respectively, as the most probable cause.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"29-31"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779687/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425004","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessing the Presence of the Joint Commission International Accreditation Requirements in Western Saudi Arabia Hospital Pharmacies: A Cross-sectional Study. 评估沙特阿拉伯西部医院药房是否符合国际联合委员会评审要求:横断面研究。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_5_23
Ahmed Ibrahim Fathelrahman, Huda Abdullah Almalki, Hanan Rashad Bajunaid, Ghaidaa Khalid Al-Harthi, Manal Omar Aljuaid, Ruqayyah Yahya Majrashi, Mohammed Abdullah Alsuwat

Objective: The Central Board of Accreditation for Healthcare Institutions (CBAHI) the national Saudi accreditation body accredited most hospitals in Saudi Arabia whereas, the Joint Commission International (JCI) a well-known international accreditation body accredited some hospitals. We assessed Western Saudi Arabia hospital pharmacists' knowledge, opinions, and observations about pharmacy-related JCI accreditation criteria needed for hospitals.

Methods: This was a cross-sectional survey-based study conducted among pharmacy personnel working in the Ministry of Health (MOH), Military, and private hospitals in the Makkah region in western Saudi Arabia. The present report represents the findings of descriptive and comparative analyses. Comparative analyses were tested by Student's t-test, analysis of variance, and Chi-square when applicable and a P ≤ 0.05 was considered statistically significant.

Findings: One hundred and one pharmacists completed the survey; most of them were from Taif (53.5%) and Jeddah (37.6%) and fewer from Makkah (8.9%). The highest proportions were from MOH (55.4%), private (29.7%), and some from military (14.9%) hospitals. They worked mostly in hospitals accredited with CBAHI (93.1%) than JCI (58.4%) and only (41.6%) worked with quality units. Correct answers on knowledge items ranged from 14.9% to 65.3%. On five-point Likert Scale, they showed supportive ratings on how they perceived the importance of JCI statement provided (overall average score: 3.78) and on how statement criteria are implemented in their hospitals (overall average score: 3.76). Higher proportions of those working in quality units compared to their counterparts were aware that accreditation cycles for JCI and CBAHI are identical (66.7% vs. 55.9%, P = 0.009) and that JCI criteria are more concise than CBAHI (59.5% vs. 52.5%, P = 0.007). Higher proportions of those working in JCI-accredited hospitals compared to their counterparts were aware that JCI criteria are clearer than CBAHI (55.9% vs. 33.3%, P = 0.021) and that JCI criteria are more concise than CBAHI (61% vs. 47.6%, P = 0.012).

Conclusion: To a high extent, pharmacists were supportive of JCI criteria and considered the criteria to be implemented in their hospitals. There is a room for improvement to enhance awareness and support of JCI quality criteria among pharmacists.

目的:沙特阿拉伯的国家评审机构--医疗机构评审中央委员会(CBAHI)对沙特阿拉伯的大多数医院进行了评审,而著名的国际评审机构--国际联合委员会(JCI)则对一些医院进行了评审。我们评估了沙特阿拉伯西部医院药剂师对医院所需的与药剂相关的 JCI 评审标准的了解、看法和意见:这是一项基于横断面调查的研究,研究对象是在沙特阿拉伯西部麦加地区的卫生部 (MOH)、军队和私立医院工作的药剂师。本报告是描述性分析和比较分析的结果。比较分析采用学生 t 检验、方差分析,适当时采用卡方检验,P ≤ 0.05 为有统计学意义:101 名药剂师完成了调查,其中大部分来自塔伊夫(53.5%)和吉达(37.6%),麦加的药剂师较少(8.9%)。来自卫生部(55.4%)、私立医院(29.7%)和军队医院(14.9%)的比例最高。他们大多在获得 CBAHI(93.1%)认证的医院工作,而不是 JCI(58.4%)认证的医院,只有(41.6%)在质量单位工作。知识项目的正确答案从 14.9% 到 65.3% 不等。在五点李克特量表中,他们对所提供的 JCI 声明的重要性(总平均分:3.78)和声明标准在医院中的实施情况(总平均分:3.76)均表示支持。与同行相比,在质量部门工作的人员中有更高比例的人知道 JCI 和 CBAHI 的评审周期相同(66.7% 对 55.9%,P = 0.009),而且 JCI 标准比 CBAHI 更简洁(59.5% 对 52.5%,P = 0.007)。在通过 JCI 认证的医院工作的药剂师中,知道 JCI 标准比 CBAHI 标准更清晰(55.9% 对 33.3%,P = 0.021)以及 JCI 标准比 CBAHI 标准更简洁(61% 对 47.6%,P = 0.012)的药剂师比例高于其他药剂师:结论:药剂师在很大程度上支持 JCI 标准,并认为应在其所在医院实施该标准。在提高药剂师对 JCI 质量标准的认识和支持方面还有待改进。
{"title":"Assessing the Presence of the Joint Commission International Accreditation Requirements in Western Saudi Arabia Hospital Pharmacies: A Cross-sectional Study.","authors":"Ahmed Ibrahim Fathelrahman, Huda Abdullah Almalki, Hanan Rashad Bajunaid, Ghaidaa Khalid Al-Harthi, Manal Omar Aljuaid, Ruqayyah Yahya Majrashi, Mohammed Abdullah Alsuwat","doi":"10.4103/jrpp.jrpp_5_23","DOIUrl":"10.4103/jrpp.jrpp_5_23","url":null,"abstract":"<p><strong>Objective: </strong>The Central Board of Accreditation for Healthcare Institutions (CBAHI) the national Saudi accreditation body accredited most hospitals in Saudi Arabia whereas, the Joint Commission International (JCI) a well-known international accreditation body accredited some hospitals. We assessed Western Saudi Arabia hospital pharmacists' knowledge, opinions, and observations about pharmacy-related JCI accreditation criteria needed for hospitals.</p><p><strong>Methods: </strong>This was a cross-sectional survey-based study conducted among pharmacy personnel working in the Ministry of Health (MOH), Military, and private hospitals in the Makkah region in western Saudi Arabia. The present report represents the findings of descriptive and comparative analyses. Comparative analyses were tested by Student's <i>t</i>-test, analysis of variance, and Chi-square when applicable and a <i>P</i> ≤ 0.05 was considered statistically significant.</p><p><strong>Findings: </strong>One hundred and one pharmacists completed the survey; most of them were from Taif (53.5%) and Jeddah (37.6%) and fewer from Makkah (8.9%). The highest proportions were from MOH (55.4%), private (29.7%), and some from military (14.9%) hospitals. They worked mostly in hospitals accredited with CBAHI (93.1%) than JCI (58.4%) and only (41.6%) worked with quality units. Correct answers on knowledge items ranged from 14.9% to 65.3%. On five-point Likert Scale, they showed supportive ratings on how they perceived the importance of JCI statement provided (overall average score: 3.78) and on how statement criteria are implemented in their hospitals (overall average score: 3.76). Higher proportions of those working in quality units compared to their counterparts were aware that accreditation cycles for JCI and CBAHI are identical (66.7% vs. 55.9%, <i>P</i> = 0.009) and that JCI criteria are more concise than CBAHI (59.5% vs. 52.5%, <i>P</i> = 0.007). Higher proportions of those working in JCI-accredited hospitals compared to their counterparts were aware that JCI criteria are clearer than CBAHI (55.9% vs. 33.3%, <i>P</i> = 0.021) and that JCI criteria are more concise than CBAHI (61% vs. 47.6%, <i>P</i> = 0.012).</p><p><strong>Conclusion: </strong>To a high extent, pharmacists were supportive of JCI criteria and considered the criteria to be implemented in their hospitals. There is a room for improvement to enhance awareness and support of JCI quality criteria among pharmacists.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"1-8"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779688/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139424982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Toxicoepidemiology of Phosphide Poisoning in the Central Part of Iran. 伊朗中部地区磷化氢中毒的毒物流行病学。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_20_23
Nastaran Eizadi-Mood, Mahnaz Momenzadeh, Masoumeh Sadeghi, Ahmad Yaraghi, Ali Mohammad Sabzghabaee, Sam Alfred

Objective: Aluminum phosphide (ALP) and zinc phosphide (ZnP) are toxic agrochemical pesticides, which are commonly used as an agent of self-harm in developing countries. Because of high toxicity of phosphides, we evaluated toxico-epidemiology ALP and ZnP poisoning in with respect to outcome.

Methods: We performed a cross-sectional study with retrospective chart review including the records for patients admitted due to phosphide poisoning (ALP, ZnP) in a poisoning referral center in Khorshid Hospital, affiliated with Isfahan University of Medial Sciences, Isfahan, Iran. Demographic characteristics, clinical manifestations, outcome (survived or death), and length of hospital stay for the patients were recorded in a data collecting form. Binary backward stepwise logistic regression was used for outcome prediction.

Findings: Sixty patients were evaluated in the study. The mean age of patients was 27.61. Thirty-nine patients were men. 96.7% of the patients ingested it intentionally. Most of the patients on admission were conscious (66.7%). Abnormality of EKG was noted in 8.3%. The mortality in ALP and ZnP poisoning was 39.2% and 22.2%, respectively. Serum bicarbonate and base excess in the venous blood gas analysis, systolic blood pressure, and serum sodium level were significantly different between patients with ALP and ZnP poisoning on admission time (P < 0.05). On admission, systolic blood pressure was an important predictive factor for mortality (odds ratio 4.87; 95% confidence interval: 1.5-15.45; P = 0.007).

Conclusion: The rate of mortality in phosphide poisoning is high. Knowing predictive factors for mortality help physicians for selecting patients in intensive care unit admission and aggressive treatment.

目的:磷化铝(ALP)和磷化锌(ZnP)是有毒的农用化学杀虫剂,在发展中国家通常被用作自残剂。由于磷化物的毒性很高,我们对 ALP 和 ZnP 中毒的毒物流行病学结果进行了评估:我们在伊朗伊斯法罕市伊斯法罕医科大学附属 Khorshid 医院的中毒转诊中心开展了一项横断面研究,并对磷化物中毒(ALP 和 ZnP)患者的病历进行了回顾性病历审查。患者的人口统计学特征、临床表现、结果(存活或死亡)和住院时间均记录在数据收集表中。结果预测采用二元后向逐步逻辑回归法:研究共评估了 60 名患者。患者的平均年龄为 27.61 岁。39 名患者为男性。96.7%的患者为故意摄入。大多数患者入院时神志清醒(66.7%)。8.3%的患者心电图异常。ALP 和锌粉中毒的死亡率分别为 39.2% 和 22.2%。静脉血气分析中的血清碳酸氢盐和碱过量、收缩压和血清钠水平在 ALP 和锌中毒患者入院时有显著差异(P < 0.05)。入院时,收缩压是预测死亡率的重要因素(几率比4.87;95%置信区间:1.5-15.45;P = 0.007):结论:磷化氢中毒的死亡率很高。结论:磷化氢中毒的死亡率很高,了解死亡率的预测因素有助于医生选择重症监护室收治的患者并进行积极治疗。
{"title":"Toxicoepidemiology of Phosphide Poisoning in the Central Part of Iran.","authors":"Nastaran Eizadi-Mood, Mahnaz Momenzadeh, Masoumeh Sadeghi, Ahmad Yaraghi, Ali Mohammad Sabzghabaee, Sam Alfred","doi":"10.4103/jrpp.jrpp_20_23","DOIUrl":"10.4103/jrpp.jrpp_20_23","url":null,"abstract":"<p><strong>Objective: </strong>Aluminum phosphide (ALP) and zinc phosphide (ZnP) are toxic agrochemical pesticides, which are commonly used as an agent of self-harm in developing countries. Because of high toxicity of phosphides, we evaluated toxico-epidemiology ALP and ZnP poisoning in with respect to outcome.</p><p><strong>Methods: </strong>We performed a cross-sectional study with retrospective chart review including the records for patients admitted due to phosphide poisoning (ALP, ZnP) in a poisoning referral center in Khorshid Hospital, affiliated with Isfahan University of Medial Sciences, Isfahan, Iran. Demographic characteristics, clinical manifestations, outcome (survived or death), and length of hospital stay for the patients were recorded in a data collecting form. Binary backward stepwise logistic regression was used for outcome prediction.</p><p><strong>Findings: </strong>Sixty patients were evaluated in the study. The mean age of patients was 27.61. Thirty-nine patients were men. 96.7% of the patients ingested it intentionally. Most of the patients on admission were conscious (66.7%). Abnormality of EKG was noted in 8.3%. The mortality in ALP and ZnP poisoning was 39.2% and 22.2%, respectively. Serum bicarbonate and base excess in the venous blood gas analysis, systolic blood pressure, and serum sodium level were significantly different between patients with ALP and ZnP poisoning on admission time (<i>P</i> < 0.05). On admission, systolic blood pressure was an important predictive factor for mortality (odds ratio 4.87; 95% confidence interval: 1.5-15.45; <i>P</i> = 0.007).</p><p><strong>Conclusion: </strong>The rate of mortality in phosphide poisoning is high. Knowing predictive factors for mortality help physicians for selecting patients in intensive care unit admission and aggressive treatment.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"21-28"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779690/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of Current Community Pharmacist Practice in Saudi Arabia: A Cross-sectional Study from Patients' Perspective (PART I). 沙特阿拉伯当前社区药剂师实践评估:从患者角度进行的横断面研究(第一部分)。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_12_23
Abdulmajeed Bajuayfir, Mohammad Alhazmi, Omar Alshareef, Ahmed Rawas, Sumayyah Alsharif, Amal Almasoudi, Ejaz Cheema, Majid Ali

Objective: This study aimed to evaluate the current practice of community pharmacists from patients' and pharmacists' perspectives in Saudi Arabia. This paper presents the patients' perspective.

Methods: A self-administered cross-sectional survey was developed to collect responses from patients in Saudi Arabia from February to April 2021. The questionnaire comprised several statements related to the best practice in community pharmacy. Patients' responses to each statement were scored using a 5-point Likert scale. Higher scores represented the greater extent to which the pharmacists perform the best practice in a community pharmacy setting and vice versa.

Findings: The data of 233 participants were included in the analysis. The majority of the participants were female (67%) and Saudi nationals (96%). The minimum mean score was related to the statement: pharmacist discusses with you about herbal medications or vitamin supplements. The maximum mean score was related to the statement: Pharmacist explains to you about the dose of medications and when to take them. Participants who were <20 years old had a significantly highest mean score, whereas those above 40 years old had the least mean score, P = 0.001. Participants from the Eastern region had a significantly highest mean score, compared to South region participants who had the least mean score, P = 0.009.

Conclusion: A gap in the current practice and the best practice of community pharmacists was found. The policymakers can utilize these findings to provide targeted professional development opportunities for the practicing community pharmacists to improve the overall service and care for the patients.

研究目的本研究旨在从患者和药剂师的角度评估沙特阿拉伯社区药剂师的现行做法。本文将从患者的角度进行阐述:2021 年 2 月至 4 月期间,在沙特阿拉伯开展了一项自填式横断面调查,以收集患者的答复。问卷包括与社区药房最佳实践相关的几项陈述。患者对每项陈述的回答均采用 5 点李克特量表进行评分。得分越高,表示药剂师在社区药房环境中执行最佳实践的程度越高,反之亦然:共有 233 名参与者的数据被纳入分析。大部分参与者为女性(67%)和沙特国民(96%)。最低平均得分与以下陈述有关:药剂师与您讨论草药或维生素补充剂。最高平均分与以下陈述有关:药剂师向您解释药物的剂量和服用时间。P = 0.001。东部地区参与者的平均得分明显最高,而南部地区参与者的平均得分最低,P = 0.009:发现社区药剂师目前的实践与最佳实践之间存在差距。政策制定者可利用这些研究结果,为执业社区药剂师提供有针对性的专业发展机会,以改善对患者的整体服务和护理。
{"title":"Evaluation of Current Community Pharmacist Practice in Saudi Arabia: A Cross-sectional Study from Patients' Perspective (PART I).","authors":"Abdulmajeed Bajuayfir, Mohammad Alhazmi, Omar Alshareef, Ahmed Rawas, Sumayyah Alsharif, Amal Almasoudi, Ejaz Cheema, Majid Ali","doi":"10.4103/jrpp.jrpp_12_23","DOIUrl":"10.4103/jrpp.jrpp_12_23","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to evaluate the current practice of community pharmacists from patients' and pharmacists' perspectives in Saudi Arabia. This paper presents the patients' perspective.</p><p><strong>Methods: </strong>A self-administered cross-sectional survey was developed to collect responses from patients in Saudi Arabia from February to April 2021. The questionnaire comprised several statements related to the best practice in community pharmacy. Patients' responses to each statement were scored using a 5-point Likert scale. Higher scores represented the greater extent to which the pharmacists perform the best practice in a community pharmacy setting and vice versa.</p><p><strong>Findings: </strong>The data of 233 participants were included in the analysis. The majority of the participants were female (67%) and Saudi nationals (96%). The minimum mean score was related to the statement: pharmacist discusses with you about herbal medications or vitamin supplements. The maximum mean score was related to the statement: Pharmacist explains to you about the dose of medications and when to take them. Participants who were <20 years old had a significantly highest mean score, whereas those above 40 years old had the least mean score, <i>P</i> = 0.001. Participants from the Eastern region had a significantly highest mean score, compared to South region participants who had the least mean score, <i>P</i> = 0.009.</p><p><strong>Conclusion: </strong>A gap in the current practice and the best practice of community pharmacists was found. The policymakers can utilize these findings to provide targeted professional development opportunities for the practicing community pharmacists to improve the overall service and care for the patients.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"15-20"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779689/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prophylaxis Effect of Metronidazole Vaginal Gel in Decreasing the Risk of Surgical Site Infections after Elective Hysterectomy. 甲硝唑阴道凝胶对降低择期子宫切除术后手术部位感染风险的预防作用
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_66_21
Fahimeh Sabet, Sara Ravan, Azar Danesh Shahraki

Objective: Infections are an important cause of morbidity and mortality after hysterectomy. Here, we aimed to investigate and evaluate the beneficial effects of metronidazole vaginal gel on the rate of surgical site infections in women undergoing elective abdominal hysterectomy.

Methods: This is a randomized prospective, double-blind controlled clinical trial performed in 2020 in Isfahan on 108 candidates for elective hysterectomy. At the beginning of the study, we completed a checklist of the patient's characteristics (patient age, body mass index [BMI], and history of medical conditions such as diabetes, hypertension, anemia, and immune deficiency) and the cause of hysterectomy. All patients were randomized into two groups. The first group received a lubricant vaginal gel single dosage, and the second group received a 0.75% metronidazole vaginal gel single dosage the night before surgery. Patients were visited up to 6 weeks after surgery, and the frequency of infection at the surgical site was determined.

Findings: The rates of infection were lower in patients who received metronidazole vaginal gel (5.8%) compared to the control group (11.6%) (P = 0.03). Patients with an estimated blood loss volume of more than 500 mL had higher rates of infection (13.46%) compared to patients with a bleeding volume of fewer than 500 mL (1.9%) (P = 0.001). We also found that patients with diabetes (13.5%) and patients with BMI more than 30 kg/m2(13.5%) had higher rates of infection compared to patients without diabetes (5.8%) and patients with BMI <30 kg/m2 (11.5%) (P = 0.001 for both). Patients with higher hospitalization duration had higher infection rates (P = 0.009).

Conclusion: Administration of a single dosage of metronidazole vaginal gel before abdominal hysterectomy may reduce surgical site infection and have clinical values.

目的:感染是子宫切除术后发病和死亡的重要原因。在此,我们旨在研究和评估甲硝唑阴道凝胶对择期腹部子宫切除术妇女手术部位感染率的有益影响:这是一项随机前瞻性双盲对照临床试验,于 2020 年在伊斯法罕对 108 名择期子宫切除术候选者进行了研究。研究开始时,我们填写了一份患者特征(患者年龄、体重指数[BMI]、糖尿病、高血压、贫血和免疫缺陷等病史)和子宫切除原因的核对表。所有患者被随机分为两组。第一组接受单剂量润滑剂阴道凝胶,第二组在手术前一晚接受单剂量 0.75% 甲硝唑阴道凝胶。术后 6 周内对患者进行访视,确定手术部位的感染频率:接受甲硝唑阴道凝胶治疗的患者感染率(5.8%)低于对照组(11.6%)(P = 0.03)。估计失血量超过 500 毫升的患者感染率(13.46%)高于出血量少于 500 毫升的患者(1.9%)(P = 0.001)。我们还发现,糖尿病患者(13.5%)和体重指数超过 30 kg/m2 的患者(13.5%)与非糖尿病患者(5.8%)和体重指数为 2 的患者(11.5%)相比,感染率更高(P = 0.001)。住院时间越长的患者感染率越高(P = 0.009):结论:腹部子宫切除术前使用单剂量甲硝唑阴道凝胶可减少手术部位感染,具有临床价值。
{"title":"Prophylaxis Effect of Metronidazole Vaginal Gel in Decreasing the Risk of Surgical Site Infections after Elective Hysterectomy.","authors":"Fahimeh Sabet, Sara Ravan, Azar Danesh Shahraki","doi":"10.4103/jrpp.jrpp_66_21","DOIUrl":"10.4103/jrpp.jrpp_66_21","url":null,"abstract":"<p><strong>Objective: </strong>Infections are an important cause of morbidity and mortality after hysterectomy. Here, we aimed to investigate and evaluate the beneficial effects of metronidazole vaginal gel on the rate of surgical site infections in women undergoing elective abdominal hysterectomy.</p><p><strong>Methods: </strong>This is a randomized prospective, double-blind controlled clinical trial performed in 2020 in Isfahan on 108 candidates for elective hysterectomy. At the beginning of the study, we completed a checklist of the patient's characteristics (patient age, body mass index [BMI], and history of medical conditions such as diabetes, hypertension, anemia, and immune deficiency) and the cause of hysterectomy. All patients were randomized into two groups. The first group received a lubricant vaginal gel single dosage, and the second group received a 0.75% metronidazole vaginal gel single dosage the night before surgery. Patients were visited up to 6 weeks after surgery, and the frequency of infection at the surgical site was determined.</p><p><strong>Findings: </strong>The rates of infection were lower in patients who received metronidazole vaginal gel (5.8%) compared to the control group (11.6%) (<i>P</i> = 0.03). Patients with an estimated blood loss volume of more than 500 mL had higher rates of infection (13.46%) compared to patients with a bleeding volume of fewer than 500 mL (1.9%) (<i>P</i> = 0.001). We also found that patients with diabetes (13.5%) and patients with BMI more than 30 kg/m<sup>2</sup>(13.5%) had higher rates of infection compared to patients without diabetes (5.8%) and patients with BMI <30 kg/m<sup>2</sup> (11.5%) (<i>P</i> = 0.001 for both). Patients with higher hospitalization duration had higher infection rates (<i>P</i> = 0.009).</p><p><strong>Conclusion: </strong>Administration of a single dosage of metronidazole vaginal gel before abdominal hysterectomy may reduce surgical site infection and have clinical values.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"9-14"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779691/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Keep Away from Children's Reach: A Missing Link of Pharmacy Practice Research. 远离儿童:药学实践研究的缺失环节。
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-11-27 eCollection Date: 2023-01-01 DOI: 10.4103/jrpp.jrpp_36_23
Mohammed Kanan
{"title":"Keep Away from Children's Reach: A Missing Link of Pharmacy Practice Research.","authors":"Mohammed Kanan","doi":"10.4103/jrpp.jrpp_36_23","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_36_23","url":null,"abstract":"","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"12 1","pages":"32"},"PeriodicalIF":1.0,"publicationDate":"2023-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10779692/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139425005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Atorvastatin Exposure and Low Folate Status: A Case-Control Study. 阿托伐他汀暴露与低叶酸状态之间的关系:一项病例对照研究。
IF 0.7 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2023-03-24 eCollection Date: 2022-07-01 DOI: 10.4103/jrpp.jrpp_66_22
Roberto Lozano, Irati Apesteguía, Alejandro Martínez

Objective: The objective of this study is to assess the association between exposure to atorvastatin (ATV) and low-plasma folate (PF) status.

Methods: The sample consisted of patients admitted to the internal medicine service of a basic general hospital, located in Zaragoza (Spain). We adopted a pharmacoepidemiological case-control study design. For this, the number of treatment days (TDs) of all the drugs part of their treatment during the study period was obtained from each patient in the sample. The cases were comprised by the number of patient's TDs for which PF ≤3 mg/dl and the controls by the number of patient's TDs for which PF >3 mg/dl. To measure the strength of the association, the odds ratios (ORs) were calculated. The Chi-square test, using the Bonferroni correction, was used to calculate the statistical significance.

Findings: The sample consisted of 640 polymedicated patients. The mean PF obtained were 8.0 ± 4.6 mg/dl and 2.1 ± 0.6 mg/dl, for the cases and controls, respectively; the total number of TDs for the cases and controls were 7615 and 57899, respectively. We obtained a U-shaped curve when representing the dose of ATV against the corresponding ORs when comparing cases with control.

Conclusion: Exposure to ATV at 10 or 80 mg is associated with an augmented risk of low folate status. We recommend implementing guidelines for mandatory folic acid fortification in patients exposed to ATV doses of 10 or 80 mg.

目的:本研究的目的是评估暴露于阿托伐他汀(ATV)和低血浆叶酸(PF)状态之间的关系。方法:以西班牙萨拉戈萨市某基础综合医院内科收治的患者为样本。我们采用药物流行病学病例对照研究设计。为此,从样本中每个患者获得研究期间所有药物部分治疗的治疗天数(TDs)。以PF≤3mg /dl的TDs数为例,以PF≤3mg /dl的TDs数为对照组。为了衡量这种关联的强度,我们计算了比值比(ORs)。采用卡方检验,采用Bonferroni校正,计算统计学显著性。结果:样本包括640例多药患者。患者和对照组的平均PF值分别为8.0±4.6 mg/dl和2.1±0.6 mg/dl;病例和对照组总td数分别为7615和57899。当将病例与对照进行比较时,我们得到了一条u形曲线,表示亚硝酸钠的剂量与相应的ORs。结论:暴露于10或80毫克的ATV与低叶酸状态的风险增加有关。我们建议对暴露于ATV剂量为10或80毫克的患者实施强制性叶酸强化指南。
{"title":"Association Between Atorvastatin Exposure and Low Folate Status: A Case-Control Study.","authors":"Roberto Lozano, Irati Apesteguía, Alejandro Martínez","doi":"10.4103/jrpp.jrpp_66_22","DOIUrl":"10.4103/jrpp.jrpp_66_22","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study is to assess the association between exposure to atorvastatin (ATV) and low-plasma folate (PF) status.</p><p><strong>Methods: </strong>The sample consisted of patients admitted to the internal medicine service of a basic general hospital, located in Zaragoza (Spain). We adopted a pharmacoepidemiological case-control study design. For this, the number of treatment days (TDs) of all the drugs part of their treatment during the study period was obtained from each patient in the sample. The cases were comprised by the number of patient's TDs for which PF ≤3 mg/dl and the controls by the number of patient's TDs for which PF >3 mg/dl. To measure the strength of the association, the odds ratios (ORs) were calculated. The Chi-square test, using the Bonferroni correction, was used to calculate the statistical significance.</p><p><strong>Findings: </strong>The sample consisted of 640 polymedicated patients. The mean PF obtained were 8.0 ± 4.6 mg/dl and 2.1 ± 0.6 mg/dl, for the cases and controls, respectively; the total number of TDs for the cases and controls were 7615 and 57899, respectively. We obtained a U-shaped curve when representing the dose of ATV against the corresponding ORs when comparing cases with control.</p><p><strong>Conclusion: </strong>Exposure to ATV at 10 or 80 mg is associated with an augmented risk of low folate status. We recommend implementing guidelines for mandatory folic acid fortification in patients exposed to ATV doses of 10 or 80 mg.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 3","pages":"124-126"},"PeriodicalIF":0.7,"publicationDate":"2023-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/16/9d/JRPP-11-124.PMC10252577.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9623251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Knowledge and Compliance of Hydroxychloroquine Prophylaxis for Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Indian Health-Care Workers. 印度医护人员对羟氯喹预防冠状病毒2型感染的知识和依从性
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-18 eCollection Date: 2022-01-01 DOI: 10.4103/jrpp.jrpp_50_21
Rudrashish Haldar, Prabhaker Mishra, Mohan Gurjar, Om Prakash Sanjeev, Vijai Datta Upadhyaya, Ankur Bhatnagar, Dharmendra Bhadauria, Vikas Agarwal

Objective: In the initial days of the coronavirus disease 2019 (COVID-19) pandemic, the Indian Council of Medical Research (ICMR) recommended the use of hydroxychloroquine (HCQ) as chemoprophylaxis for health-care workers (HCWs) involved in the care of COVID-19 patients. The present survey aimed to assess the knowledge and compliance of HCQ prophylaxis as per the ICMR recommendations among Indian HCWs during the first wave of the pandemic.

Methods: A validated 19-item questionnaire-based survey was distributed to HCWs in our apex tertiary care institute who had completed their duties in the COVID-19 wards to assess the knowledge, attitude, and compliance of all sections of HCWs regarding the ICMR-recommended HCQ prophylaxis. Participation in the survey was voluntary, and anonymity was maintained. Data obtained from the responses were collated and analyzed.

Findings: Two hundred and fourteen out of 250 HCWs completed the survey (85.6% response rate). Among 214 participants, 87.9% were below the age of 40 years. 83.2% were aware of the use of HCQ for possible prevention of COVID-19 infection, while only 24.6% took HCQ for 7 weeks as was recommended during that period. The main reasons given by 37.3% of the HCWs for not taking HCQ were their knowledge and research on HCQ, where side effects were prominent. Side effects were reported by 35% of the respondents, of which the most notable was nausea/vomiting (14%) followed by gastritis (12%).

Conclusion: The poor compliance with HCQ prophylaxis by HCWs was influenced by their knowledge and research, lack of strong scientific evidence, and drug-associated adverse effects.

目的:在2019冠状病毒病(COVID-19)大流行的最初几天,印度医学研究委员会(ICMR)建议参与护理COVID-19患者的卫生保健工作者(HCWs)使用羟氯喹(HCQ)作为化学预防药物。本调查旨在评估印度卫生保健工作者在大流行第一波期间根据ICMR建议对HCQ预防的了解和遵守情况。方法:对我院三级医疗机构完成新冠肺炎病区职责的医护人员进行问卷调查,评估各科室医护人员对icmr推荐的HCQ预防的知识、态度和依从性。参与调查是自愿的,并保持匿名。从回复中获得的数据被整理和分析。结果:250名医护人员中有214名完成了调查,回应率为85.6%。214名参与者中,87.9%的人年龄在40岁以下。83.2%的人知道使用HCQ可以预防COVID-19感染,而只有24.6%的人在此期间按照建议服用了7周HCQ。37.3%的医护人员不服用盐酸环己烷醇的主要原因是对盐酸环己烷醇的了解和研究,其中副作用突出。35%的应答者报告了副作用,其中最显著的是恶心/呕吐(14%),其次是胃炎(12%)。结论:卫生保健工作者对HCQ预防依从性较差,主要受其自身知识和研究水平、缺乏强有力的科学依据和药物相关不良反应的影响。
{"title":"Knowledge and Compliance of Hydroxychloroquine Prophylaxis for Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Indian Health-Care Workers.","authors":"Rudrashish Haldar,&nbsp;Prabhaker Mishra,&nbsp;Mohan Gurjar,&nbsp;Om Prakash Sanjeev,&nbsp;Vijai Datta Upadhyaya,&nbsp;Ankur Bhatnagar,&nbsp;Dharmendra Bhadauria,&nbsp;Vikas Agarwal","doi":"10.4103/jrpp.jrpp_50_21","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_50_21","url":null,"abstract":"<p><strong>Objective: </strong>In the initial days of the coronavirus disease 2019 (COVID-19) pandemic, the Indian Council of Medical Research (ICMR) recommended the use of hydroxychloroquine (HCQ) as chemoprophylaxis for health-care workers (HCWs) involved in the care of COVID-19 patients. The present survey aimed to assess the knowledge and compliance of HCQ prophylaxis as per the ICMR recommendations among Indian HCWs during the first wave of the pandemic.</p><p><strong>Methods: </strong>A validated 19-item questionnaire-based survey was distributed to HCWs in our apex tertiary care institute who had completed their duties in the COVID-19 wards to assess the knowledge, attitude, and compliance of all sections of HCWs regarding the ICMR-recommended HCQ prophylaxis. Participation in the survey was voluntary, and anonymity was maintained. Data obtained from the responses were collated and analyzed.</p><p><strong>Findings: </strong>Two hundred and fourteen out of 250 HCWs completed the survey (85.6% response rate). Among 214 participants, 87.9% were below the age of 40 years. 83.2% were aware of the use of HCQ for possible prevention of COVID-19 infection, while only 24.6% took HCQ for 7 weeks as was recommended during that period. The main reasons given by 37.3% of the HCWs for not taking HCQ were their knowledge and research on HCQ, where side effects were prominent. Side effects were reported by 35% of the respondents, of which the most notable was nausea/vomiting (14%) followed by gastritis (12%).</p><p><strong>Conclusion: </strong>The poor compliance with HCQ prophylaxis by HCWs was influenced by their knowledge and research, lack of strong scientific evidence, and drug-associated adverse effects.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 1","pages":"33-39"},"PeriodicalIF":1.0,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/53/f7/JRPP-11-33.PMC9585800.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40677568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community Pharmacists' Services during the COVID-19 Pandemic: A Case Study of Lagos State, Nigeria. COVID-19大流行期间社区药剂师的服务:以尼日利亚拉各斯州为例
IF 1 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-18 eCollection Date: 2022-01-01 DOI: 10.4103/jrpp.jrpp_5_22
Ogochukwu U Amaeze, Alexander A Akinola, Ayobami A Aiyeolemi, Folasade O Lawal, Oghogho R Ijomone, Ugochukwu A Mbata

Objective: To explore the services community pharmacists in Lagos state provided to their communities during the COVID-19 pandemic.

Methods: A cross-sectional survey of community pharmacists drawn from all the Association of Community Pharmacists' zones in Lagos state was done from April to June 2021. Data were collected using a structured, self-reported online questionnaire via Google Forms and were analyzed using descriptive and inferential statistical analysis.

Findings: Two hundred and forty community pharmacists participated in the study; the response rate was 80.5%. Patient counseling (99.6%), assessment and treatment of common acute ailments (99.6%), and patient education on hygiene (99.6%) were the most reported services provided by community pharmacists. The COVID-19 infection prevention and control measures most frequently practiced by the pharmacists include cleaning of floors with soap and water (98.4%), provision of hand sanitizers for staff use (97.1%), and taking precautions when handling prescriptions and dispensing drugs (96.7%). Significant barriers to the provision of the services were reduced workforce in the pharmacy, time constraints, and extended working hours. Zinc (98.3%), Vitamin C (97.5%), and ivermectin (95.0%) tablets were the most reported medications for the prevention and treatment of COVID-19 infection.

Conclusion: Community pharmacists in Lagos state actively provide pharmacy services and practice various recommended infection prevention and control measures to mitigate the spread of COVID-19 infection in their communities.

目的:了解拉各斯州社区药师在2019冠状病毒病疫情期间为社区提供的服务情况。方法:于2021年4月至6月对拉各斯州所有社区药剂师协会区域的社区药剂师进行横断面调查。数据收集采用结构化,自我报告的在线问卷通过谷歌表格,并使用描述性和推断性统计分析进行分析。结果:240名社区药剂师参与了这项研究;应答率为80.5%。社区药师提供的服务最多的是患者咨询(99.6%)、常见急性病评估与治疗(99.6%)和患者卫生教育(99.6%)。药剂师最常采取的新冠肺炎防控措施包括:用肥皂和水清洁地板(98.4%)、提供工作人员使用的洗手液(97.1%)、在处理处方和配药时采取预防措施(96.7%)。提供服务的主要障碍是药房劳动力减少、时间限制和工作时间延长。锌片(98.3%)、维生素C片(97.5%)和伊维菌素片(95.0%)是报告最多的预防和治疗COVID-19感染的药物。结论:拉各斯州社区药师积极提供药学服务,并实施各种推荐的感染防控措施,缓解了COVID-19感染在社区的传播。
{"title":"Community Pharmacists' Services during the COVID-19 Pandemic: A Case Study of Lagos State, Nigeria.","authors":"Ogochukwu U Amaeze,&nbsp;Alexander A Akinola,&nbsp;Ayobami A Aiyeolemi,&nbsp;Folasade O Lawal,&nbsp;Oghogho R Ijomone,&nbsp;Ugochukwu A Mbata","doi":"10.4103/jrpp.jrpp_5_22","DOIUrl":"https://doi.org/10.4103/jrpp.jrpp_5_22","url":null,"abstract":"<p><strong>Objective: </strong>To explore the services community pharmacists in Lagos state provided to their communities during the COVID-19 pandemic.</p><p><strong>Methods: </strong>A cross-sectional survey of community pharmacists drawn from all the Association of Community Pharmacists' zones in Lagos state was done from April to June 2021. Data were collected using a structured, self-reported online questionnaire via Google Forms and were analyzed using descriptive and inferential statistical analysis.</p><p><strong>Findings: </strong>Two hundred and forty community pharmacists participated in the study; the response rate was 80.5%. Patient counseling (99.6%), assessment and treatment of common acute ailments (99.6%), and patient education on hygiene (99.6%) were the most reported services provided by community pharmacists. The COVID-19 infection prevention and control measures most frequently practiced by the pharmacists include cleaning of floors with soap and water (98.4%), provision of hand sanitizers for staff use (97.1%), and taking precautions when handling prescriptions and dispensing drugs (96.7%). Significant barriers to the provision of the services were reduced workforce in the pharmacy, time constraints, and extended working hours. Zinc (98.3%), Vitamin C (97.5%), and ivermectin (95.0%) tablets were the most reported medications for the prevention and treatment of COVID-19 infection.</p><p><strong>Conclusion: </strong>Community pharmacists in Lagos state actively provide pharmacy services and practice various recommended infection prevention and control measures to mitigate the spread of COVID-19 infection in their communities.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 1","pages":"25-32"},"PeriodicalIF":1.0,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/c0/JRPP-11-25.PMC9585806.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40655552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perception of Health Professionals and the General Population Regarding the Use of Antibiotics and Antibiotic Resistance in Puducherry, South India. 南印度普杜切里卫生专业人员和普通民众对抗生素使用和抗生素耐药性的看法。
IF 0.8 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2022-08-18 eCollection Date: 2022-01-01 DOI: 10.4103/jrpp.jrpp_8_22
Priyadharsini Raman Palanisamy, Vimala Ananthy, Umamaheswari Subramanian

Objective: The present study aims to evaluate the awareness of a sample of the general population and health-care professionals regarding the use of antibiotics and antibiotic resistance and identify the factors associated with antibiotic resistance.

Methods: This prospective questionnaire-based study was conducted for 3 months, from July to September 2020, in Karaikal, Puducherry (India). The health professionals included doctors in pre- and paraclinical teaching departments (those not involved in clinical practice), laboratory technicians, and PhD students pharmacists. The questionnaire had two parts which health professionals answered, whereas the general population answered only the second part.

Findings: About 38.5% of the population reported using antibiotics frequently among the responses obtained. Around 66.5% of the general population usually stop the antibiotic within 1 or 2 days after they feel better, and 11% of the people believed that adding an extra antibiotic would make them better. Among the health professionals, more than 90% responded that self-medication is the major reason for antibiotic resistance and was unsure of the overprescription of antibiotics.

Conclusion: The results show variable responses and suggest the need for intervention programs to increase the knowledge among the general population regarding the rational use of antibiotics.

目的:本研究旨在评估普通人群和医疗保健专业人员对抗生素使用和抗生素耐药性的认识,并确定与抗生素耐药性相关的因素:本研究旨在评估普通人群和医疗保健专业人员对抗生素使用和抗生素耐药性的认识,并确定与抗生素耐药性相关的因素:这项前瞻性问卷调查研究于 2020 年 7 月至 9 月在印度普都切里卡拉卡尔进行,为期 3 个月。参与调查的卫生专业人员包括临床前和临床旁教学部门的医生(不参与临床实践)、实验室技术人员和药剂师博士生。问卷分为两部分,医疗专业人员回答了第一部分,而普通民众只回答了第二部分:在收到的答复中,约 38.5%的人表示经常使用抗生素。约 66.5%的普通人群通常会在感觉病情好转后 1 到 2 天内停用抗生素,11%的人认为多加一种抗生素会使病情好转。在卫生专业人员中,超过 90% 的人回答说,自我药疗是抗生素耐药性的主要原因,并不确定抗生素的过量处方:结果显示,人们的回答各不相同,这表明有必要开展干预计划,以提高普通民众对合理使用抗生素的认识。
{"title":"Perception of Health Professionals and the General Population Regarding the Use of Antibiotics and Antibiotic Resistance in Puducherry, South India.","authors":"Priyadharsini Raman Palanisamy, Vimala Ananthy, Umamaheswari Subramanian","doi":"10.4103/jrpp.jrpp_8_22","DOIUrl":"10.4103/jrpp.jrpp_8_22","url":null,"abstract":"<p><strong>Objective: </strong>The present study aims to evaluate the awareness of a sample of the general population and health-care professionals regarding the use of antibiotics and antibiotic resistance and identify the factors associated with antibiotic resistance.</p><p><strong>Methods: </strong>This prospective questionnaire-based study was conducted for 3 months, from July to September 2020, in Karaikal, Puducherry (India). The health professionals included doctors in pre- and paraclinical teaching departments (those not involved in clinical practice), laboratory technicians, and PhD students pharmacists. The questionnaire had two parts which health professionals answered, whereas the general population answered only the second part.</p><p><strong>Findings: </strong>About 38.5% of the population reported using antibiotics frequently among the responses obtained. Around 66.5% of the general population usually stop the antibiotic within 1 or 2 days after they feel better, and 11% of the people believed that adding an extra antibiotic would make them better. Among the health professionals, more than 90% responded that self-medication is the major reason for antibiotic resistance and was unsure of the overprescription of antibiotics.</p><p><strong>Conclusion: </strong>The results show variable responses and suggest the need for intervention programs to increase the knowledge among the general population regarding the rational use of antibiotics.</p>","PeriodicalId":17158,"journal":{"name":"Journal of Research in Pharmacy Practice","volume":"11 1","pages":"8-12"},"PeriodicalIF":0.8,"publicationDate":"2022-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/05/JRPP-11-8.PMC9585803.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40566408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Research in Pharmacy Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1